New Betulin Derivatives in Combination with Rimantadine for Inhibition of Influenza Virus Reproduction
Abstract
The preliminary studies mainly revealed comparable inhibition activities of 3-oxime of betulonic acid, 3^-O-acetyl-28-O-hemiph-thalate of betulin and 3,28-dioxime of betulin against reproduction of influenza viruses A (H1N1), A (H7N1), A (H3N2) and B, as well as against the strains of influenza virus A (H1N1) with intrinsic resistance to rimantadine and A (H7N1) with acquired resistance to the drug. The level of the activity depended on the system used for the virus reproduction. The highest level was observed under conditions providing higher permissibivity, i.e. in the chick embryo fibroblast cell culture for A (H7N1) and in fragments of chick embryo chorioallantoic membranes (for all the viruses). In the experiments with virus A/FPV/Rostock/34 (H7N1) in the chick embryo fibroblast cell culture the average effective concentrations (EC50) of the triterpene compounds were 10.4-17.5 mcM in comparison to EC50 of rimantadine (0.014 mcM). The use of every of the compounds in combination with rimantadine resulted in a 2-16 times decrease of their EC50 and correction of the concentration-effect relation of rimantadine. However, when rimantadine was used alone within the higher range of the nontoxic concentrations (11.6-57.6 mcM). its antiviral properties were significantly less pronounced. As a result the virus titer difference in comparison to the control within the above range of the rimantadine concentrations increased from < 1 to > 2.35 lg PPU/ml and the relations of the maximal tolerance concentrations of the compounds to their EC50 increased 1.7-15.9 times.
About the Authors
O. V. Savinova
Institute of Epidemiology and Microbiology of the Ministry of Health of the Byelorussian Republic, Minsk
Russian Federation
Russian Federation
N. I. Pavlova
Institute of Epidemiology and Microbiology of the Ministry of Health of the Byelorussian Republic, Minsk
Russian Federation
Russian Federation
E. I. Boreko
Institute of Epidemiology and Microbiology of the Ministry of Health of the Byelorussian Republic, Minsk
Russian Federation
Russian Federation
References
1. Conly J. M., Johnston B. L. Ode to oseltamivir and amantadine? Can J Infect Dis Med Microbiol 2006: 17: 1: 11-14.
2. Гендон Ю. 3. Вакцины и химиопрепараты для профилактики гриппа. Вопр вирусол 2007; 52: 1: 4-10.
3. Deyde V. M., Gubareva I. V., Xu X. et al. Surveillance of resistance to amantadines among influenza A (H2N2) and A (H1N1) viruses isolated worldwide (2005-2007).
4. Sheu T. G., Deyde V. M., Okomo-Adhiambo M. et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide in 2004-2008. Antimicrob Agents Chemother 2008; 52: 9: 3284-3292.
5. McKimm-Breschkin J. L., Sellek P. W., Usman T. B., Johnson M. A. Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis 2007; 13: 9: 1354-1357.
6. Rameix-Welti M.-A., Enouf V., Culevier F. et al. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLOS Pathogens 2008; 4: 7: 1-5.
7. Boreko E. I., Pavlova N. I., Savinova O. V. et al. Inhibition of virus reproduction and proteinase activity by lupane and some other terpenes. News of Biomed. Sci. (Весцї НАН Беларусь Сер. Мед-биол. навук), 2002; 3: 86-90.
8. Вотяков В. И. Актуальные задачи в научной разработке соединений с антивирусными свойствами. Молекулярн. биол. вирусов, химиотерапия и химиопрофилактика вирусн. инфекций: Мат. объед. сессии отд. гигиены, микробиол. и эпидемиол. Минск, 1974; 10-28.
9. Вотяков В. И., Бореко Е. И., Владыко Г. В. и др. Первичное изучение антивирусных свойств синтетических и природных соединений: Метод рек. Минск, 1986; 26.
10. Савинова О. В., Павлова Н. И., Бореко Е. И. Активность тритерпено-вых соединений и известных противогриппозных препаратов в отношении вирусов гриппа. Здравоохранение (Минск), 2008; 11: 65-67.
11. Fung K. P. A computer program in basic for estimation of ED50 and LD50. Comput Biol Med 1989; 19: 2: 131-135.
12. Janz C., Wigand R. Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus. Arch. Virol 1982; 73: 135-143.
13. Бореко Е. И., Павлова H. И., Вотяков В. И. Изменение чувствительности вируса гриппа, размножившегося в присутствии ремантадина, к противовирусным препаратам. Вопр вирусол 1999; 3: 115-119.
14. Aiken C., Ho C. C. Betulinic acid derivatives as HIV-1 antivirals. Trends in Mol. Med 2005; 11: 1: 31-36.
15. Huang L., Yuan X., Aiken C., Chen C. H. Bifunctional anti-human immunodeficiency virus type I small molecules with two novel mechanisms of action. Antimicrob Agents Chemother 2004; 48: 2: 663-665.
16. Kanamoto T., Kashiwada Y., Kanbara K. et al. Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation. Ibid; 2001; 45: 4: 1225-1230.
Review
For citations:
Savinova O.V., Pavlova N.I., Boreko E.I. New Betulin Derivatives in Combination with Rimantadine for Inhibition of Influenza Virus Reproduction. Antibiot Khimioter = Antibiotics and Chemotherapy. 2009;54(5-6):16-20. (In Russ.)
Views:
404
Email this article 